Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease - Wikidata - wikimedia - TriplyDB

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

http://www.wikidata.org/entity/Q42555027

about

Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice MicroRNAs in the Host Response to Viral Infections of Veterinary Importance The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis MicroRNAs in Neurotoxicity Application of "omics" to prion biomarker discovery.Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population.Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques.MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.MicroRNAs: master regulators of ethanol abuse and toxicity?MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing.A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP.A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome.MicroRNA and messenger RNA profiling reveals new biomarkers and mechanisms for RDX induced neurotoxicity.Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis)Population differences in microRNA expression and biological implications.MicroRNA networks direct neuronal development and plasticity.Formaldehyde and epigenetic alterations: microRNA changes in the nasal epithelium of nonhuman primates.Synthetic pre-microRNAs reveal dual-strand activity of miR-34a on TNF-α.MiRNA expression profiles in the brains of mice infected with scrapie agents 139A, ME7 and S15.Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery.MicroRNAs in neurodegenerative diseases and their therapeutic potential.Small RNA drugs for prion disease: a new frontier.Exosomes: the future of biomarkers in medicine.MicroRNA in intervertebral disc degeneration.microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges.microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.miRNAs as biomarkers of neurodegenerative disorders.Analysis of miRNA Signatures in Neurodegenerative Prion Disease.Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease.Fixed differences in the 3'UTR of buffalo PRNP gene provide binding sites for miRNAs post-transcriptional regulation Differential Expression of MicroRNAs in Leprosy Skin Lesions.A miRNA expression signature that separates between normal and malignant prostate tissues.Let's make microglia great again in neurodegenerative disorders.Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases.

P2860

Q21129257-3A5568FB-434C-49B4-99F0-953EDB9A6AA5 Q24607278-446CA582-E188-4A5F-9BE4-4468D21B0CFA Q27340506-6E92AD8F-0357-45DE-A195-35BC15881DDA Q28078710-C257F2C3-FDBC-4136-8E6F-0EF57F51FD1B Q28271675-34BB3419-63A3-44FE-A9AA-37CD8C8156C9 Q28382954-282EF562-1AE4-435D-83AD-EDC39D05A14F Q33708360-21295031-8D43-44ED-8D40-8C75CF47A3DF Q33761898-6E739594-C7C2-4188-84E2-43F4FD22882A Q33770606-4B6FB692-2248-459C-9605-0032802FEB96 Q33961392-20F8C8BC-BBA0-42A2-883A-98F21F5FEE91 Q34078032-F2DDBFE3-F2B7-40A3-AAC7-115D441AD3B6 Q34101214-08E5E2ED-35C2-4B9E-AD1A-796D338BCDE6 Q34123440-6C9C8FDE-7C2F-4E97-9954-FDD5A3007CB8 Q34416679-FD4C5126-1859-446A-82BC-CA7CD4B697F8 Q34812498-485BE0AF-4873-46EB-94C7-AD1788BFBBFC Q34813357-ADEDFAB4-15D2-4DC3-9AE4-43FC0C37CD8F Q35005163-B6B3E450-E604-4F17-B534-6ADEB900E363 Q35155029-4759088F-8EED-45CD-B619-2320784603A8 Q35578546-A9706D8A-43C2-48DD-8639-6BECA407A70C Q35644179-EB14FB33-E914-4E86-AA44-F765D048CD1C Q36752327-9313997C-6CD6-42EC-9369-9A1E5FA16DD4 Q37400278-347230AB-11AD-45AF-86FA-756FF1BFCB4E Q37489927-54E86CA0-A33C-48B2-BDB7-DA3AC34F5ED9 Q37664297-90DADB9C-CD09-4444-AD4F-8632EBB146CC Q37946984-1F57E1BD-7044-4067-8822-CB494AF08E65 Q38121120-AEE45C8B-9AD4-452A-90E4-2E7A3F1EE208 Q38138606-33D327FA-52CD-4A63-A37A-2894A5D4EB34 Q38367405-0FB96405-186C-44D9-9D0F-214303969161 Q38375953-73C392AB-B15B-45EA-8646-A22F20E8906A Q38648154-2C9675F7-73CF-489D-9A65-0DD276C9B984 Q38911621-F9D977A4-6B5A-4A1B-97A2-B616CD48A06B Q39104808-8E9A04C3-A32F-4461-82EB-E82E9A710970 Q40071129-3D62F7C1-33E1-4C6C-8786-1DB5C70F21A1 Q40209615-22B6B7D6-82FF-4C34-84E7-817FEB6CBAF4 Q41233893-EB7DBBD3-D553-480C-BC11-26FBCA3546E6 Q41991878-FD2905CD-958C-4CB8-907B-BC6BA3870949 Q42230002-63CD6EDB-5241-426D-97A0-F26B0656CAB9 Q46926746-68A47A95-F091-45BE-8A4F-8EFBF84D9BE5 Q47550368-3CE9C4C1-9290-4E87-949B-17E0EAB80877 Q55004951-80622447-17B0-4ECD-B87E-1AD51816BBFF

P2860

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

http://www.wikidata.org/entity/Q42555027

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

@en

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

@nl

type

label

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

@en

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

@nl

prefLabel

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

@en

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

@nl

P1433

Q42555027-1CD0A325-8218-4B2E-9301-2D770029B5C2

P1476

Q42555027-D1663E19-8F2B-4D23-B169-52FB58345598

P2093

Q42555027-40F6B0FE-08D0-4656-9C20-5B741C6FA0B3

Q42555027-6AFB58C0-90AF-4546-B5AD-4D760854BE7D

Q42555027-9047A07E-D3D1-48E9-8914-5630DD3D1523

Q42555027-B1F699D9-4B9A-4AA1-AE2D-AC93DB65EF18

Q42555027-C60D0DB2-CD20-4B03-9A12-88499E930587

P2860

Q42555027-1DF0A4C8-535D-4A46-983C-8C43F82597DC

Q42555027-24753393-6F14-4FB4-BE53-B6ABE3CF2188

Q42555027-27666A12-4B94-4053-BEAD-897D8D678FE5

Q42555027-37D4B8A7-7BD8-4A52-A337-89EEE2EE2D09

Q42555027-42E91199-40A2-4B2A-8DC5-28AE7E685F32

Q42555027-4C00F113-345C-426C-A887-437F0B67B40B

Q42555027-502CA1FC-AFB2-4B1C-81D8-F8A2A719E1AA

Q42555027-530166BB-D27B-4614-9F12-88A6AC39A3A8

Q42555027-5EC74755-DFF2-4BD7-B51D-60E71C0C48E1

Q42555027-5FA0AAB8-E448-4846-B8E7-DE7869EB3562

P2888

Q42555027-8E7E5664-E7DF-412E-A4A7-A3B82F84022A

P304

Q42555027-2AD77F40-8AA9-46C4-BADF-25062086B2D3

P31

Q42555027-4D745049-EBC1-4856-A17D-EB1A8DA3BB70

P356

Q42555027-2F5CB08B-BE35-478A-995F-0831B522FF69

P478

Q42555027-2B52221F-0361-4646-AF52-AC77A77D59DE

P50

Q42555027-B9187C8A-F5AA-4BF3-8ABB-E13F5CA3DA02

P577

Q42555027-8F5AC08D-9B77-4CE5-90E9-3D47E99FB3F6

P5875

Q42555027-0E04BCAF-B59F-4EA5-8930-FD15BF3832D9

P6179

Q42555027-52ED8B31-C682-4113-AB99-1F8755A33C7B

P698

Q42555027-01864A78-61C0-4DC9-A916-2F0F3E55DD34

P921

Q42555027-A797D719-CF6F-42D5-A4D5-54B8C89D1E91

P932

Q42555027-4F334E10-0326-4859-90DD-CD0FC7B37899

P356

P1433

Molecular Neurodegeneration

P1476

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

@en

P2093

Dirk Motzkus

http://www.w3.org/2001/XMLSchema#string

Gerhard Hunsmann

http://www.w3.org/2001/XMLSchema#string

Judith Montag

http://www.w3.org/2001/XMLSchema#string

Reiner Hitt

http://www.w3.org/2001/XMLSchema#string

Walter J Schulz-Schaeffer

http://www.w3.org/2001/XMLSchema#string

P2860

A miRNA signature of prion induced neurodegeneration

Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes

An optimized isolation and labeling platform for accurate microRNA expression profiling.

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

A mammalian microRNA expression atlas based on small RNA library sequencing

Cerebellar neurodegeneration in the absence of microRNAs

Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.

Prediction of mammalian microRNA targets

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia

The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease

P2888

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1326-4-36

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26772363

http://www.w3.org/2001/XMLSchema#string

P6179

1029059163

http://www.w3.org/2001/XMLSchema#string

P698

19712440

http://www.w3.org/2001/XMLSchema#string

P921

Prion protein family

P932

2743691

http://www.w3.org/2001/XMLSchema#string